Argentina Women’s Health Market Size & Outlook, 2023-2030
Argentina women’s health market, 2018-2030 (US$M)
Related Markets
Argentina women’s health market highlights
- The Argentina women’s health market generated a revenue of USD 247.6 million in 2023 and is expected to reach USD 388.0 million by 2030.
- The Argentina market is expected to grow at a CAGR of 6.6% from 2024 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2023.
- Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.
Women’s health market data book summary
| Market revenue in 2023 | USD 247.6 million |
| Market revenue in 2030 | USD 388.0 million |
| Growth rate | 6.6% (CAGR from 2023 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Endometriosis & Uterine Fibroids |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, Argentina accounted for 0.6% of the global women’s health market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil women’s health market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 863.6 million by 2030.
Contraceptives was the largest segment with a revenue share of 43.7% in 2023. Horizon Databook has segmented the Argentina women’s health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing patient pool, growing awareness, and government initiatives are some of the key factors driving the women’s health market in Argentina. For instance, according to a study published by PubMed, around 19% of women aged 50 and older in the country have osteoporosis.
Moreover, according to the International Osteoporosis Foundation, around 50% of postmenopausal women have osteopenia and 25% have osteoporosis; by 2050, the number of osteopenia and osteoporosis cases is projected to reach 5.24 million and 2.62 million women, respectively.
According to the World Bank statistics from 2020, Argentina's current health spending, including health services, accounts for 9.98% of the country's annual GDP. Argentina lacks proper healthcare coverage; over 36% of its population does not have any formal healthcare coverage and is dependent on the public healthcare system.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women’s Health Market Scope
Women’s Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Argentina women’s health market size, by application, 2018-2030 (US$M)
Argentina Women’s Health Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
